Bailard’s iRadimed IRMD Stock Holding History

Bailard’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,600	Closed	-$202K	–	767
2024 Q2	$202K	Buy	+4,600	New	+$196K	0.01%	688

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bailard's IRMD Position: Q3 2024 in Review

Bailard sold out of iRadimed (IRMD) in Q3 2024, closing a stake of 4,600 shares — an estimated $202K sold.

Bailard first reported a position in IRMD in Q2 2024 and held it in 1 quarter. The position peaked at $202K in Q2 2024. 144 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.

Bailard reported no remaining iRadimed position as of Q3 2024 after selling out during the quarter.
Bailard sold 4,600 iRadimed shares in Q3 2024, an estimated $202K.
Bailard first reported a position in iRadimed in Q2 2024 and held it in 1 quarter.
Bailard's iRadimed position peaked at $202K in Q2 2024.
144 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.

Based on Bailard's 13F filing for Q3 2024, filed 30 Oct 2024.